TLR4 and cancer: Because DOCK11 has been shown to recruit TLR4, leading to the activation of CDC42 and the promotion of cell migration, and TLR4 has been implicated in promoting epithelial-mesenchymal transition (EMT) and the migration of cancer cells, we may speculate that DOCK11 is associated with cancer-induced pathological cell migration.